{"id":251,"date":"2025-07-07T00:20:14","date_gmt":"2025-07-07T00:20:14","guid":{"rendered":"https:\/\/t1des.net\/?p=251"},"modified":"2025-07-08T15:47:10","modified_gmt":"2025-07-08T15:47:10","slug":"what-is-t-zield-and-why-is-it-so-revolutionary","status":"publish","type":"post","link":"https:\/\/t1des.net\/?p=251","title":{"rendered":"What is TZield, and Why is it so Revolutionary?"},"content":{"rendered":"<div class=\"wp-block-post-author\"><div class=\"wp-block-post-author__avatar\"><img alt='' src='https:\/\/secure.gravatar.com\/avatar\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=48&#038;d=mm&#038;r=g' srcset='https:\/\/secure.gravatar.com\/avatar\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=96&#038;d=mm&#038;r=g 2x' class='avatar avatar-48 photo' height='48' width='48' \/><\/div><div class=\"wp-block-post-author__content\"><p class=\"wp-block-post-author__byline\">Written by<\/p><p class=\"wp-block-post-author__name\"><a href=\"https:\/\/t1des.net\/?author=1\" target=\"_self\">Navami Muglurmath<\/a><\/p><\/div><\/div>\n\n<p><span style=\"font-weight: 400;\">For decades, type 1 diabetes (T1D) has been a disease without a possible cure. Diagnosed most often in children and adolescents, it\u2019s an autoimmune condition where the body\u2019s immune system attacks insulin-producing beta cells in the pancreas. Once those cells are gone, they can\u2019t regenerate, and patients are left managing the disease for life with insulin therapy.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">However, in 2022, the FDA made a groundbreaking decision: Tzield (teplizumab-mzwv) was approved, the first and only drug currently shown to delay the onset of type 1 diabetes. For the first time in medical history, we have a treatment that doesn&#8217;t just manage T1D\u2013it actually modifies the disease process. Here\u2019s what makes Tzield so incredible.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-family: 'times new roman', times; font-size: 26px;\"><b>What is Tzield?<\/b><\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">Tzield is a humanized anti-CD3 monoclonal antibody, which is a type of immunotherapy that targets CD3, a molecule found on the surface of T-cells. T-cells are key in the autoimmune destruction of the pancreas in the T1D disease process. By binding to CD3, Tzield temporarily modifies the activity of these T-cells, reducing their attack on pancreatic beta cells.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">The medication doesn\u2019t cure T1D or stop the disease completely. However, it does delay its clinical onset\u2013the point at which someone requires insulin treatment\u2013by an average of 2 years. This delay can be life-changing, especially for young children or teenagers who would otherwise need to start insulin treatments immediately after diagnosis.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-family: 'times new roman', times; font-size: 26px;\"><b>The Role of Autoantibodies and Screening<\/b><\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">To understand how Tzield works, it\u2019s essential to understand how we can detect T1D before symptoms appear. In most cases, people are diagnosed only after they show symptoms like excessive thirst, frequent urination, weight loss, and severe fatigue. At that point, it\u2019s possible they have already lost 80-90% of their insulin-producing beta cells.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">However, science now allows us to detect T1D in its pre-symptomatic stages through islet autoantibody screening. These autoantibodies\u2013such as IAA, GAD65, IA-2, and ZnT8\u2013are markers in the blood that signal the immune system has begun attacking the pancreas. The presence of two or more of these autoantibodies is highly predictive of T1D.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">That\u2019s where Tzield steps in. It\u2019s indicated for people aged 8 and older who are in Stage 2 T1D\u2013meaning they have tested positive for multiple autoantibodies and abnormal blood sugar levels, but have not exhibited clinical symptoms yet. Administered as a 14-day IV infusion, Tzield can delay the transition to Stage 3 T1D, which is when the patient requires insulin therapy.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-family: 'times new roman', times; font-size: 26px;\"><b>Why Tzield is so Revolutionary<\/b><\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">For one, it shifts the T1D treatment process from the reaction stage to the prevention stage. Tzield introduces a pre-emptive treatment strategy\u2013intervening before symptoms occur to preserve remaining beta cell function.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">It also gives families time. A 2-year delay in diagnosis means postponing the need for insulin injections, blood sugar monitoring, and the pressure of managing diabetes. This can also delay risks of diabetic ketoacidosis. Most importantly, it gives families time to process the diagnosis and set up a care plan for the future.<\/span><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">Tzield is the first disease-modifying drug in T1D, but it most likely won\u2019t be the last. Its approval by the FDA opened up doors for the exploration of immunotherapies and combination treatments with the hope of curing the disease altogether.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">Wider autoantibody screening in children, especially those with a family history of T1D, is likely to become more common in coming years, as early detection becomes critical for intervention. Education outreach is needed to inform families that it\u2019s now possible to delay T1D, and that this delay could offer major benefits.\u00a0<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">It\u2019s also important to note that access to Tzield could present challenges. As of 2024, a full course of Tzield could cost hundreds of thousands of dollars. Ongoing advocacy and policy changes will be key in ensuring Tzield becomes part of standard pre-T1D management.<\/span><\/p>\n<p>\u00a0<\/p>\n<p><span style=\"font-weight: 400;\">Tzield doesn\u2019t stop the progression of type 1 diabetes completely, but it slows it down in a way we\u2019ve never seen before. For families at risk, it offers time. For the future of diabetes care, it\u2019s a groundbreaking discovery that can lead to more research benefitting the lives of people predisposed to type 1 diabetes everywhere.\u00a0<\/span><\/p>\n<p>\u00a0<\/p>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-dots\"\/>\n\n\n<p>\u00a0<\/p>\n<p style=\"text-align: center;\"><strong><span style=\"font-size: 26px;\">Sources<\/span><\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Herold, Kevan C., et al. \u201cAn Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.\u201d <\/span><i><span style=\"font-weight: 400;\">New England Journal of Medicine<\/span><\/i><span style=\"font-weight: 400;\">, vol. 381, no. 7, 15 Aug. 2019, pp. 603\u2013613, www.nejm.org\/doi\/full\/10.1056\/nejmoa1902226, <\/span><a href=\"https:\/\/doi.org\/10.1056\/nejmoa1902226\"><span style=\"font-weight: 400;\">https:\/\/doi.org\/10.1056\/nejmoa1902226<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kawasaki, Eiji. \u201cAnti-Islet Autoantibodies in Type 1 Diabetes.\u201d <\/span><i><span style=\"font-weight: 400;\">International Journal of Molecular Sciences<\/span><\/i><span style=\"font-weight: 400;\">, vol. 24, no. 12, 11 June 2023, pp. 10012\u201310012, www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10298549\/, <\/span><a href=\"https:\/\/doi.org\/10.3390\/ijms241210012\"><span style=\"font-weight: 400;\">https:\/\/doi.org\/10.3390\/ijms241210012<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cWhy TZIELD\u00ae? | TZIELD\u00ae (Teplizumab-Mzwv).\u201d <\/span><i><span style=\"font-weight: 400;\">TZIELD\u00ae (Teplizumab-Mzwv) Patient Site<\/span><\/i><span style=\"font-weight: 400;\">, <\/span><a href=\"http:\/\/www.tzield.com\/about-tzield\/why-tzield\"><span style=\"font-weight: 400;\">www.tzield.com\/about-tzield\/why-tzield<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>For decades, type 1 diabetes (T1D) has been a disease without a possible cure. Diagnosed most often in children and adolescents, it\u2019s an autoimmune condition where the body\u2019s immune system attacks insulin-producing beta cells in the pancreas. Once those cells are gone, they can\u2019t regenerate, and patients are left managing the disease for life with [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":252,"comment_status":"open","ping_status":"open","sticky":false,"template":"single-with-sidebar","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-251","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-education"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What is TZield, and Why is it so Revolutionary? - T1DES.NET<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/t1des.net\/?p=251\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What is TZield, and Why is it so Revolutionary? - T1DES.NET\" \/>\n<meta property=\"og:description\" content=\"For decades, type 1 diabetes (T1D) has been a disease without a possible cure. Diagnosed most often in children and adolescents, it\u2019s an autoimmune condition where the body\u2019s immune system attacks insulin-producing beta cells in the pancreas. Once those cells are gone, they can\u2019t regenerate, and patients are left managing the disease for life with [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/t1des.net\/?p=251\" \/>\n<meta property=\"og:site_name\" content=\"T1DES.NET\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-07T00:20:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-08T15:47:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/t1des.net\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-06-at-8.19.51-PM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1242\" \/>\n\t<meta property=\"og:image:height\" content=\"1196\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Navami Muglurmath\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Navami Muglurmath\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251\"},\"author\":{\"name\":\"Navami Muglurmath\",\"@id\":\"http:\\\/\\\/t1des.net\\\/#\\\/schema\\\/person\\\/3acca40d5955a4f86d8cab835cf61f5b\"},\"headline\":\"What is TZield, and Why is it so Revolutionary?\",\"datePublished\":\"2025-07-07T00:20:14+00:00\",\"dateModified\":\"2025-07-08T15:47:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251\"},\"wordCount\":789,\"commentCount\":0,\"publisher\":{\"@id\":\"http:\\\/\\\/t1des.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/t1des.net\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Screenshot-2025-07-06-at-8.19.51-PM.png\",\"articleSection\":[\"Education\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/t1des.net\\\/?p=251#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251\",\"url\":\"https:\\\/\\\/t1des.net\\\/?p=251\",\"name\":\"What is TZield, and Why is it so Revolutionary? - T1DES.NET\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/t1des.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/t1des.net\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Screenshot-2025-07-06-at-8.19.51-PM.png\",\"datePublished\":\"2025-07-07T00:20:14+00:00\",\"dateModified\":\"2025-07-08T15:47:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/t1des.net\\\/?p=251\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251#primaryimage\",\"url\":\"https:\\\/\\\/t1des.net\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Screenshot-2025-07-06-at-8.19.51-PM.png\",\"contentUrl\":\"https:\\\/\\\/t1des.net\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Screenshot-2025-07-06-at-8.19.51-PM.png\",\"width\":1242,\"height\":1196},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/t1des.net\\\/?p=251#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/t1des.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What is TZield, and Why is it so Revolutionary?\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/t1des.net\\\/#website\",\"url\":\"http:\\\/\\\/t1des.net\\\/\",\"name\":\"T1DES.NET\",\"description\":\"Early diagnosis makes a lasting impact.\",\"publisher\":{\"@id\":\"http:\\\/\\\/t1des.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/t1des.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/t1des.net\\\/#organization\",\"name\":\"T1DES.NET\",\"url\":\"http:\\\/\\\/t1des.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/t1des.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/t1des.net\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/CA11A04F-47AD-4A17-89C5-B4A41F7E463D.png\",\"contentUrl\":\"https:\\\/\\\/t1des.net\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/CA11A04F-47AD-4A17-89C5-B4A41F7E463D.png\",\"width\":1192,\"height\":1184,\"caption\":\"T1DES.NET \"},\"image\":{\"@id\":\"http:\\\/\\\/t1des.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/t1des.net\\\/#\\\/schema\\\/person\\\/3acca40d5955a4f86d8cab835cf61f5b\",\"name\":\"Navami Muglurmath\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=96&d=mm&r=g\",\"caption\":\"Navami Muglurmath\"},\"description\":\"Navami is a co-founder and Director of Marketing at T1DES. She is a high school senior passionate about healthcare education and type 1 diabetes advocacy. Through her writing, she hopes to spread awareness of the disease in her community. In her free time, she likes to listen to music, read, and scrapbook.\",\"sameAs\":[\"https:\\\/\\\/t1des.net\"],\"url\":\"https:\\\/\\\/t1des.net\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What is TZield, and Why is it so Revolutionary? - T1DES.NET","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/t1des.net\/?p=251","og_locale":"en_US","og_type":"article","og_title":"What is TZield, and Why is it so Revolutionary? - T1DES.NET","og_description":"For decades, type 1 diabetes (T1D) has been a disease without a possible cure. Diagnosed most often in children and adolescents, it\u2019s an autoimmune condition where the body\u2019s immune system attacks insulin-producing beta cells in the pancreas. Once those cells are gone, they can\u2019t regenerate, and patients are left managing the disease for life with [&hellip;]","og_url":"https:\/\/t1des.net\/?p=251","og_site_name":"T1DES.NET","article_published_time":"2025-07-07T00:20:14+00:00","article_modified_time":"2025-07-08T15:47:10+00:00","og_image":[{"width":1242,"height":1196,"url":"https:\/\/t1des.net\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-06-at-8.19.51-PM.png","type":"image\/png"}],"author":"Navami Muglurmath","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Navami Muglurmath","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/t1des.net\/?p=251#article","isPartOf":{"@id":"https:\/\/t1des.net\/?p=251"},"author":{"name":"Navami Muglurmath","@id":"http:\/\/t1des.net\/#\/schema\/person\/3acca40d5955a4f86d8cab835cf61f5b"},"headline":"What is TZield, and Why is it so Revolutionary?","datePublished":"2025-07-07T00:20:14+00:00","dateModified":"2025-07-08T15:47:10+00:00","mainEntityOfPage":{"@id":"https:\/\/t1des.net\/?p=251"},"wordCount":789,"commentCount":0,"publisher":{"@id":"http:\/\/t1des.net\/#organization"},"image":{"@id":"https:\/\/t1des.net\/?p=251#primaryimage"},"thumbnailUrl":"https:\/\/t1des.net\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-06-at-8.19.51-PM.png","articleSection":["Education"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/t1des.net\/?p=251#respond"]}]},{"@type":"WebPage","@id":"https:\/\/t1des.net\/?p=251","url":"https:\/\/t1des.net\/?p=251","name":"What is TZield, and Why is it so Revolutionary? - T1DES.NET","isPartOf":{"@id":"http:\/\/t1des.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/t1des.net\/?p=251#primaryimage"},"image":{"@id":"https:\/\/t1des.net\/?p=251#primaryimage"},"thumbnailUrl":"https:\/\/t1des.net\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-06-at-8.19.51-PM.png","datePublished":"2025-07-07T00:20:14+00:00","dateModified":"2025-07-08T15:47:10+00:00","breadcrumb":{"@id":"https:\/\/t1des.net\/?p=251#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/t1des.net\/?p=251"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/t1des.net\/?p=251#primaryimage","url":"https:\/\/t1des.net\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-06-at-8.19.51-PM.png","contentUrl":"https:\/\/t1des.net\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-06-at-8.19.51-PM.png","width":1242,"height":1196},{"@type":"BreadcrumbList","@id":"https:\/\/t1des.net\/?p=251#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/t1des.net\/"},{"@type":"ListItem","position":2,"name":"What is TZield, and Why is it so Revolutionary?"}]},{"@type":"WebSite","@id":"http:\/\/t1des.net\/#website","url":"http:\/\/t1des.net\/","name":"T1DES.NET","description":"Early diagnosis makes a lasting impact.","publisher":{"@id":"http:\/\/t1des.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/t1des.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"http:\/\/t1des.net\/#organization","name":"T1DES.NET","url":"http:\/\/t1des.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/t1des.net\/#\/schema\/logo\/image\/","url":"https:\/\/t1des.net\/wp-content\/uploads\/2024\/10\/CA11A04F-47AD-4A17-89C5-B4A41F7E463D.png","contentUrl":"https:\/\/t1des.net\/wp-content\/uploads\/2024\/10\/CA11A04F-47AD-4A17-89C5-B4A41F7E463D.png","width":1192,"height":1184,"caption":"T1DES.NET "},"image":{"@id":"http:\/\/t1des.net\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"http:\/\/t1des.net\/#\/schema\/person\/3acca40d5955a4f86d8cab835cf61f5b","name":"Navami Muglurmath","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f0c56a5a519446d6d5d36171195c6867369e094be96db5e0ebb435e3dbc1efa6?s=96&d=mm&r=g","caption":"Navami Muglurmath"},"description":"Navami is a co-founder and Director of Marketing at T1DES. She is a high school senior passionate about healthcare education and type 1 diabetes advocacy. Through her writing, she hopes to spread awareness of the disease in her community. In her free time, she likes to listen to music, read, and scrapbook.","sameAs":["https:\/\/t1des.net"],"url":"https:\/\/t1des.net\/?author=1"}]}},"brizy_media":[],"_links":{"self":[{"href":"https:\/\/t1des.net\/index.php?rest_route=\/wp\/v2\/posts\/251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/t1des.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/t1des.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/t1des.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/t1des.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=251"}],"version-history":[{"count":5,"href":"https:\/\/t1des.net\/index.php?rest_route=\/wp\/v2\/posts\/251\/revisions"}],"predecessor-version":[{"id":273,"href":"https:\/\/t1des.net\/index.php?rest_route=\/wp\/v2\/posts\/251\/revisions\/273"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/t1des.net\/index.php?rest_route=\/wp\/v2\/media\/252"}],"wp:attachment":[{"href":"https:\/\/t1des.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/t1des.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/t1des.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}